Rathore, A. S., Kumar, S., Konwar, R., Makker, A., Negi, M., & Goel, M. M. (2014). CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. Indian J Med Res.
Chicago Style CitationRathore, Ankita Singh, Sandeep Kumar, Rituraj Konwar, Annu Makker, M.P.S Negi, i Madhu Mati Goel. "CD3+, CD4+ & CD8+ Tumour Infiltrating Lymphocytes (TILs) Are Predictors of Favourable Survival Outcome in Infiltrating Ductal Carcinoma of Breast." Indian J Med Res 2014.
Cita MLARathore, Ankita Singh, et al. "CD3+, CD4+ & CD8+ Tumour Infiltrating Lymphocytes (TILs) Are Predictors of Favourable Survival Outcome in Infiltrating Ductal Carcinoma of Breast." Indian J Med Res 2014.